Product Information
PALIPERIDONE ER 3 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.9719 per EA under NDC 62332080430. Its NADAC has been published 44 times since Dec 3, 2025.
FDA first approved this application on Sep 26, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332080430
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PALIPERIDONEApproval Type
Generic (ANDA)
FDA Application
ANDA218330FDA Approved
9/26/2024
TE Code
AB
On Market Since
9/30/2024
Pharmacological Classes
Price Statistics
The NADAC for PALIPERIDONE ER 3 MG TABLET has been published 44 times since Dec 3, 2025, and over the history we have for it it has declined 22.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9719 per EA |
|---|---|
| All-time high | $1.2598 (Dec 10, 2025) |
| All-time low | $0.9120 (Aug 19, 2026) |
| 52-week high | $1.2598 |
| 52-week low | $0.9120 |
| Median price | $1.0998 |
| Average price | $1.0645 |
| Largest weekly change | -9.4% (Jun 17, 2026) |
| Weeks tracked | 44 |
| Tracking since | Dec 3, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
paliperidone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PALIPERIDONE ER 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PALIPERIDONE ER 3 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.9719 per EA (NDC 62332080430), effective Sep 30, 2026.
How has the price of PALIPERIDONE ER 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for PALIPERIDONE ER 3 MG TABLET has declined 22.9%. It has been tracked across 44 weekly CMS publications since Dec 3, 2025.
What are the highest and lowest recorded NADAC prices for PALIPERIDONE ER 3 MG TABLET?
Since Dec 3, 2025, the NADAC for PALIPERIDONE ER 3 MG TABLET has ranged from a low of $0.9120 (Aug 19, 2026) to a high of $1.2598 (Dec 10, 2025), with a median of $1.0998 per EA.
Are there cheaper alternatives to PALIPERIDONE ER 3 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PALIPERIDONE ER 3 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PALIPERIDONE ER 3 MG TABLET?
PALIPERIDONE ER 3 MG TABLET (NDC 62332080430) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.